JP2006518197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006518197A5 JP2006518197A5 JP2006501525A JP2006501525A JP2006518197A5 JP 2006518197 A5 JP2006518197 A5 JP 2006518197A5 JP 2006501525 A JP2006501525 A JP 2006501525A JP 2006501525 A JP2006501525 A JP 2006501525A JP 2006518197 A5 JP2006518197 A5 JP 2006518197A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- lna
- ras
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200300184 | 2003-02-10 | ||
| DKPA200301539 | 2003-10-20 | ||
| PCT/DK2004/000097 WO2004069992A2 (en) | 2003-02-10 | 2004-02-10 | Oligomeric compounds for the modulation of ras expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006518197A JP2006518197A (ja) | 2006-08-10 |
| JP2006518197A5 true JP2006518197A5 (cg-RX-API-DMAC7.html) | 2007-03-22 |
Family
ID=32852146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501525A Withdrawn JP2006518197A (ja) | 2003-02-10 | 2004-02-10 | ラス発現の改変のためのオリゴマー化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040248840A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1592795A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006518197A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004209599A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2515644A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004069992A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2649817T3 (es) | 2002-04-05 | 2018-01-15 | Roche Innovation Center Copenhagen A/S | Compuestos oligom¿¿ricos para la modulaci¿®n de la expresi¿®n de HIF-1¿Á |
| US20040241717A1 (en) * | 2003-02-10 | 2004-12-02 | Santaris Pharma A/S | Oligomeric compounds for the modulation of thioredoxin expression |
| US7713738B2 (en) * | 2003-02-10 | 2010-05-11 | Enzon Pharmaceuticals, Inc. | Oligomeric compounds for the modulation of survivin expression |
| EP1824975B9 (en) * | 2004-11-09 | 2011-04-20 | Santaris Pharma A/S | Lna oligonucleotides and the treatment of cancer |
| BRPI0515726A8 (pt) | 2004-11-09 | 2017-09-12 | Santaris Pharma As | Oligonucleotídeos de lna potentes para a inibição de expressão de hif-1a |
| US9447138B2 (en) | 2004-11-09 | 2016-09-20 | Roche Innovation Center Copenhagen A/S | Potent LNA oligonucleotides for the inhibition of HIF-1a expression |
| US20060234277A1 (en) * | 2005-03-31 | 2006-10-19 | Amgen Inc. | Method for selectively blocking hemoglobin RNA amplification |
| WO2007068113A1 (en) * | 2005-12-16 | 2007-06-21 | Mcgill University | 4'-thioarabinonucleotide-containing oligonucleotides, compounds and methods for their preparation and uses thereof |
| CA3042781C (en) * | 2006-04-03 | 2021-10-19 | Roche Innovation Center Copenhagen A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| AU2007323469B2 (en) * | 2006-11-23 | 2014-07-24 | Guangdong Maijinjia Biotechnology Co., Ltd | Oligonucleotides for modulating target RNA activity |
| EP2001188A1 (en) * | 2007-06-08 | 2008-12-10 | F.Hoffmann-La Roche Ag | Method for authenticating a medical device and a remote device |
| CN101821722A (zh) * | 2007-06-29 | 2010-09-01 | 霍夫曼-拉罗奇有限公司 | 用于优化在医疗装置和远程电子装置之间的通信的装置和方法 |
| ES2715277T3 (es) * | 2007-06-29 | 2019-06-03 | Hoffmann La Roche | Aparato y método para controlar de manera remota un dispositivo médico ambulatorio |
| JP5723154B2 (ja) | 2007-09-19 | 2015-05-27 | アプライド バイオシステムズ リミテッド ライアビリティー カンパニー | RNAiにおけるオフターゲット表現型の影響を減少させるためのSiRNA配列非依存性修飾フォーマットおよびその安定化型 |
| NZ585327A (en) * | 2007-11-26 | 2012-10-26 | Santaris Pharma As | Lna antagonists targeting the androgen receptor |
| US7863437B2 (en) * | 2007-12-03 | 2011-01-04 | Enzon Pharmaceuticals, Inc. | RNA antagonist compounds for the modulation of PIK3CA expression |
| US8846637B2 (en) | 2010-06-08 | 2014-09-30 | Isis Pharmaceuticals, Inc. | Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom |
| EP2633052B1 (en) * | 2010-10-27 | 2018-04-11 | CuRNA, Inc. | Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1 |
| HK1200484A1 (zh) | 2011-09-14 | 2015-08-07 | Translate Bio Ma, Inc. | 多聚寡核苷酸化合物 |
| CN104254610A (zh) * | 2012-03-12 | 2014-12-31 | 桑塔里斯制药公司 | 调节atxn3表达的组合物和方法 |
| CN104583402A (zh) | 2012-05-16 | 2015-04-29 | Rana医疗有限公司 | 用于调节mecp2表达的组合物和方法 |
| EA201492120A1 (ru) | 2012-05-16 | 2015-10-30 | Рана Терапьютикс, Инк. | Композиции и способы для модулирования экспрессии atp2a2 |
| JP2015523854A (ja) | 2012-05-16 | 2015-08-20 | ラナ セラピューティクス インコーポレイテッド | Smn遺伝子ファミリー発現を調節するための組成物及び方法 |
| US10837014B2 (en) | 2012-05-16 | 2020-11-17 | Translate Bio Ma, Inc. | Compositions and methods for modulating SMN gene family expression |
| CN104540946A (zh) | 2012-05-16 | 2015-04-22 | Rana医疗有限公司 | 用于调节utrn表达的组合物和方法 |
| US10174315B2 (en) | 2012-05-16 | 2019-01-08 | The General Hospital Corporation | Compositions and methods for modulating hemoglobin gene family expression |
| US20150247141A1 (en) | 2012-09-14 | 2015-09-03 | Rana Therapeutics, Inc. | Multimeric oligonucleotide compounds |
| US9029335B2 (en) | 2012-10-16 | 2015-05-12 | Isis Pharmaceuticals, Inc. | Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom |
| JP6429264B2 (ja) * | 2013-11-12 | 2018-11-28 | 学校法人東京理科大学 | ボラノホスフェート化合物、及び核酸オリゴマー |
| EP3083960B1 (en) | 2013-12-16 | 2021-02-03 | Syddansk Universitet | Ras exon 2 skipping for cancer treatment |
| CA2975525A1 (en) | 2015-02-04 | 2016-08-11 | F. Hoffmann-La Roche Ag | Tau antisense oligomers and uses thereof |
| US20180023081A1 (en) * | 2015-02-04 | 2018-01-25 | Bristol-Myers Squibb Company | Lna oligonucleotides with alternating flanks |
| ES2893114T3 (es) | 2015-02-04 | 2022-02-08 | Bristol Myers Squibb Co | Métodos para seleccionar moléculas terapéuticas |
| WO2016130943A1 (en) * | 2015-02-13 | 2016-08-18 | Rana Therapeutics, Inc. | Hybrid oligonucleotides and uses thereof |
| US11306312B2 (en) * | 2017-09-01 | 2022-04-19 | Thomas Jefferson University | Compositions and methods for MYC messenger RNA inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
| US5935779A (en) * | 1988-11-03 | 1999-08-10 | Igen International Inc. | Methods for improved particle electrochemiluminescence assay |
| US5962218A (en) * | 1988-11-03 | 1999-10-05 | Igen International Inc. | Methods and apparatus for improved luminescence assays |
| EP0590082B1 (en) * | 1991-06-14 | 1999-10-27 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of the ras gene |
| US5872242A (en) * | 1992-10-05 | 1999-02-16 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of ras |
| US6794499B2 (en) * | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| WO2001048190A2 (en) * | 1999-12-23 | 2001-07-05 | Exiqon A/S | Therapeutic uses of lna-modified oligonucleotides |
| WO2002097114A2 (en) * | 2001-05-29 | 2002-12-05 | Sirna Therapeutics, Inc. | Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv |
| US7713738B2 (en) * | 2003-02-10 | 2010-05-11 | Enzon Pharmaceuticals, Inc. | Oligomeric compounds for the modulation of survivin expression |
| US20040241717A1 (en) * | 2003-02-10 | 2004-12-02 | Santaris Pharma A/S | Oligomeric compounds for the modulation of thioredoxin expression |
-
2004
- 2004-02-10 WO PCT/DK2004/000097 patent/WO2004069992A2/en not_active Ceased
- 2004-02-10 AU AU2004209599A patent/AU2004209599A1/en not_active Abandoned
- 2004-02-10 EP EP04709582A patent/EP1592795A2/en not_active Withdrawn
- 2004-02-10 JP JP2006501525A patent/JP2006518197A/ja not_active Withdrawn
- 2004-02-10 US US10/776,917 patent/US20040248840A1/en not_active Abandoned
- 2004-02-10 CA CA002515644A patent/CA2515644A1/en not_active Abandoned
-
2006
- 2006-12-15 US US11/640,123 patent/US20080188432A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6626101B2 (ja) | GalNAcホスホラミダイト、その核酸結合体およびそれらの使用 | |
| KR101878587B1 (ko) | 올리고머 및 올리고머 접합체 | |
| US10041074B2 (en) | Euchromatic region targeting methods for modulating gene expression | |
| ES2509140T3 (es) | Fármacos de ácido nucleico ENA que modifican el corte y empalme en precursores de ARNm | |
| JP7798836B2 (ja) | B型肝炎感染の治療用のPAPD5及びPAPD7 mRNAを低減させるための核酸分子 | |
| CN110832077B (zh) | 用于抑制α-ENaC表达的RNAi剂及使用方法 | |
| US10758558B2 (en) | Hybrid oligonucleotides and uses thereof | |
| EP3442983A1 (en) | TRITYL-MONO-Ga1NAc COMPOUNDS AND THEIR USE | |
| US20150225722A1 (en) | Methods for selective targeting of heterochromatin forming non-coding rna | |
| CN104755621A (zh) | 癌症治疗 | |
| JP2010505432A5 (cg-RX-API-DMAC7.html) | ||
| JP2010524486A (ja) | β−カテニンを調節するためのRNAアンタゴニスト化合物 | |
| CN105247052A (zh) | B-细胞cll/淋巴瘤11a(bcl11a)的寡核苷酸调节剂及其用途 | |
| EP3256590A1 (en) | Targeting oligonucleotides and uses thereof to modulate gene expression | |
| KR20190047025A (ko) | 변형된 올리고뉴클레오티드 및 사용 방법 | |
| US20100249219A1 (en) | Short rna antagonist compounds for the modulation of hif-1alpha | |
| JP2021524277A (ja) | Rtel1発現の調節用のオリゴヌクレオチド | |
| JP2012529279A (ja) | 新規の強力な抗apobアンチセンス化合物 | |
| JP2011505798A (ja) | Mcl−1を調節するためのRNAアンタゴニスト化合物 | |
| JP2004526737A5 (cg-RX-API-DMAC7.html) | ||
| CN115485381A (zh) | 以apoc3为靶点的反义核酸 | |
| EP4493694A1 (en) | Modified gapmer oligomers and methods of use thereof | |
| WO2018130583A1 (en) | Antisense oligonucleotides for modulating nfkb1 expression | |
| US20250115909A1 (en) | Compounds for inhibiting amanzi | |
| US20250115914A1 (en) | Compounds for inhibition of il-1beta expression |